GRML

Greenland Mines Ltd. Common Stock (GRML)

Stock · NASDAQ · Health Care

$4.88as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$0.26355
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Fundamentals

Market cap
$24.38M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

Greenland Mines Ltd. Common Stock Competitors

Chosen by industry and closest market cap.

  • GRML
    Greenland Mines Ltd. Common Stock
    $4.88
    ▼ 7.22%
    Market cap $24.38MP/E
  • ALGS
    Aligos Therapeutics Inc. Common Stock
    $6.93
    ▼ 1.98%
    Market cap $28.47MP/E
    $3.98$13.69
  • ESLA
    Estrella Immunopharma Inc. Common Stock
    $0.705
    ▼ 2.10%
    Market cap $30.12MP/E
    $0.6781$3.15
  • JSPR
    Jasper Therapeutics Inc. Common Stock
    $0.6782
    ▼ 2.98%
    Market cap $16.98MP/E
    $0.3151$2.96
  • PASG
    Passage Bio Inc. Common Stock
    $4.52
    ▲ 4.39%
    Market cap $14.40MP/E
    $3.29$20
  • SNTI
    Senti Biosciences Holdings Inc. Common Stock
    $0.377
    ▼ 0.26%
    Market cap $11.53MP/E
    $0.3305$2.88
  • INTS
    Intensity Therapeutics Inc. Common stock
    $4.25
    ▲ 0.95%
    Market cap $11.51MP/E
    $3.51$43.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
1.78M
Disposed
175.0K

Institutional Ownership

March 31, 2026

Total shares held
9.35M
Total value held
$3.02M
Institutional holders
24
Top holders this quarter
  • Unknown5.37M
  • Unknown1.07M
  • Unknown740.5K
  • Unknown577.3K
  • Unknown370.0K
  • Unknown203.2K
  • Unknown200.0K
  • Unknown196.4K
  • Unknown143.5K
  • Unknown136.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.